secwatch.observer — SEC 8-K summary
======================================

Issuer:     Absci Corp (ABSI)
CIK:        0001672688
Form:       8-K
Filed at:   2023-03-30T23:59:59+00:00
Accession:  0001628280-23-009897
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Absci Q4 2022 net loss $19.5M; full-year loss $104.9M; cash $164.4M; 10 new Active Programs in 2023
--------------------------------------------------------------------------------

- Q4 2022 revenue $1.6M, net loss $19.5M vs $25.2M loss in Q4 2021.
- Full-year 2022 revenue $5.7M, net loss $104.9M vs $101.0M loss in 2021.
- Cash, equivalents, and short-term investments $164.4M as of Dec 31, 2022, down from $252.6M.
- Achieved zero-shot generative AI creation of de novo antibodies; hit rate 5-30x greater than baselines.
- 2023 outlook: at least 10 new Active Programs; gross cash use ~$90M, below prior year $105M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1672688/000162828023009897/0001628280-23-009897-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1672688/000162828023009897/absc-20230330.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-009897

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer